Source: 5th Sleep and Breathing Conference
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Sophia E. Schiza. Minimally symptomatic obstructive sleep apnoea: to treat or not to treat?. 5th Sleep and Breathing Conference

Member's Comments

No comment yet.

Related content which might interest you: Non-sleepy obstructive sleep apnoea: to treat or not to treat? Source: Eur Respir Rev, 28 (154) 190031; 10.1183/16000617.0031-2019 Year: 2019 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Obese children with obstructive sleep apnoea syndrom: how to treat? Source: International Congress 2019 – Phenotypes and personalised treatment of obstructive sleep apnoea in children Year: 2019 Surgical approaches to the treatment of obstructive sleep apnea Source: Virtual Congress 2020 – New technologies for the management of COPD and obstructive sleep apnea and the diagnosis of lung cancer Year: 2020 Tailoring surgical interventions to treat obstructive sleep apnoea: one size does not fit all Source: Breathe, 14 (3) e84; 10.1183/20734735.020118 Year: 2018 Treatment of obstructive sleep apnoea: differential surgical approach Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003 Selection of surgical approach in treatment of obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 572s Year: 2004 Positional therapy for obstructive sleep apnea: do your patients use it at home? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Personalised approach to treatment of children with obstructive sleep apnoea: what is the evidence? Source: Sleep and Breathing Conference 2021 Year: 2021 Advances in the surgical treatment of obstructive sleep apnoea Source: International Congress 2017 – Multidisciplinary management of sleep apnoea Year: 2017 Severe obstructive sleep apnea (OSA) and orthognathic surgery: a case of success Source: International Congress 2019 – CCC Sleep and breathing disorders Year: 2019 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Electrical stimulation in obstructive sleep apnoea: the less invasive the better? Source: Eur Respir J, 55 (2) 1902013; 10.1183/13993003.02013-2019 Year: 2020 Perioperative screening for obstructive sleep apnoea and treatment outcomes: where are the data? Source: Eur Respir J 2016; 48: 21-22 Year: 2016 Predicting outcome of nasal surgery in patients with obstructive sleep apnoea Source: Eur Respir J 2008; 32: 246 Year: 2008 Metabolic syndrome in moderate to severe obstructive sleep apnea? Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007 Should caffeine be avoided in obstructive sleep apnea? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Treating obstructive sleep apnoea to improve control of hypertension Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013